Epidemiologic breast cancer research at the UW-Madison: A summary of past accomplishments and future directions

Wisconsin Medical Journal

Volumn 108, Issue 5, 2009, Pages 284-285

  Trentham Dietz, Amy ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MORTALITY; OBESITY; POSTMENOPAUSE; STROKE; UNITED STATES; UNIVERSITY; WOMEN'S HEALTH; BREAST TUMOR; INCIDENCE; MEDICAL RESEARCH;

BIOMEDICAL RESEARCH; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; UNIVERSITIES; WISCONSIN;

EID: 70350504875     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ries LAG, Melbert D, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD. Based on November 2007 SEER data submission, posted to the SEER Web site, 2008. http://seer.cancer.gov/ csr/1975-2005/. Accessed June 27, 2009.
2. American Cancer Society. Wisconsin Cancer Facts & Figures. January 2007. http://dhs. wisconsin.gov/wcrs/pubs.htm. Accessed June 27, 2009.
3. Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed Mortality File 1999-2005. CDC WONDER On-line Database, compiled from Compressed Mortality File 1999-2005 Series 20 No. 2K, 2008. http://wonder. cdc.gov/cmf-icd10.html. Accessed June 28, 2009.
4. Lantz PM, Remington PL, Newcomb PA. Mammography screening and increased incidence of breast cancer in Wisconsin. J Natl Cancer Inst. 1991;83:1540-1546.
5. Berry DA, Cronin KA, Plevritis SK, et al, Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784-1792.
6. Hays J, Hunt JR, Hubbell FA, et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol. 2003;13:S18-S77.
7. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in health postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA. 2002;288:321-333.
8. Newcomb PA, Titus-Ernstoff L, Egan KM, et al. Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarker Prev 2002;11:593-600.
9. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004;291:47-53.
10. Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast cancer incidence in 2003 in the United States. N Engl J Med. 2007;356:1670-1674.
11. Breen N, Cronin KA, Meissner HI, et al. Reported drop in mammography: is this cause for concern? Cancer. 2007;109:2405-2409.
12. MacMahon B, Cole P. Is the incidence of breast cancer declining? Epidemiology. 2008;19:268-269.
13. Fryback DF, Stout NK, Rosenberg MA, Trentham-Dietz A, Kuruchittham V, Remington PL. The Wisconsin Breast Cancer Epidemiology Simulation Model. J Natl Cancer Inst Monogr. 2006;36:37-47.
14. Trentham-Dietz A, Newcomb PA, Storer BE, et al. Body size and risk of breast cancer. Am J Epidemiol. 1997;145:1011-1019.
15. Trentham-Dietz A, Newcomb PA, Egan KM, et al. Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control. 2000;11:533-542.
16. Reeves MJ, Newcomb PA, Remington PL, Marcus PM, MacKenzie WR. Body mass and breast cancer: relationship between method of detection and stage of disease. Cancer. 1996;77:301-307.
17. Trentham-Dietz A, Newcomb PA, Hampton JM. Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res Treat. 2007;105(2):195-207.
18. Nichols HB, Trentham-Dietz A, Egan KM, et al. Body mass index before and after breast cancer diagnosis: associations with allcause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev. (In press.)